Since 18 of December 2019 conferences.iaea.org uses Nucleus credentials. Visit our help pages for information on how to Register and Sign-in using Nucleus.

Scientific Programme

The conference will review important clinical aspects and appropriate use of medical imaging for the entire spectrum of cancer management and other diseases. It will have the following specific objectives:
  • To review the important clinical aspects of cancer and other diseases, and evaluate the role of streamlined and emerging multimodality imaging techniques in providing best pracitces in the clinical management of the diseases;
  • To evaluate, using a clinical systems based approach, the current status of clinical positron emission tomography-computed tomography (PET-CT) and other relevant imaging modalities;
  • To improve the performance of clinical practice through 'read with the experts' sessions and discussions;
  • To interact with the user community (nuclear physicians, radiologists, oncologists, radiation oncologists, technologists, radiographers, radiopharmacists, radiochemists, medical physicists and other scientists working in all aspects of molecular imaging) and provide them with the most important information in the field;
  • To provide theoretical tools on ethics, leadership and education which will prepare participants to be future leaders in the field of medical imaging; and
  • To exchange information in the field of radiopharmaceutical sciences.
The IAEA invites participants to provide high quality contirbutions on all aspects of PET-CT and molecular imaging. Recognizing that many Member States are still in the planning stage of acquiring clinical PET-CT, the Conference Secretariat emphasizes that such countries can positively contribute with papers on the applications of nuclear medicine and diagnostic imaging techniques. Both academic and practice-based papers under the umbrella of the following topics will be welcome:
  • Application of PET-CT, molecular imaging and diagnostic imaging for different types of cancer: breast, lung, colorectal, melanoma, neuroendocrine, etc.;
  • PET-CT for radiation treatment planning;
  • Radiopharmaceutical production: good manufacturing practices and quality assurance;
  • PET and single photon emission computed tomography (SPECT) physics, instrumentation and data analysis;
  • Quality management in nuclear medicine and diagnostic imaging;
  • Radiation protection for personnel and dose reduction for patients;
  • Member State experience with PET, multimodality imaging and newer applications in diagnostic imaging; and
  • Ethics, leadership and education for nuclear medicine and diagnostic imaging professionals.
Target Audience

This conference will offer the opportunity to review the latest developments in the field of PET-CT and diagnostic imaging. The target audience comprises:
  • Nuclear medicine physicians;
  • Radiologists;
  • Radiation oncologists;
  • Technologists and radiographers;
  • Medical physicists;
  • Radiochemists and radiopharmacists; and
  • Other scientists working in all aspects of molecular imaging.
Topics

Abstracts on the following topics will be considered for presentation at the conference.

  • Hybrid imaging or other imaging techniques in gynecological cancers

  • Hybrid imaging or other imaging techniques in pediatric cancers

  • Hybrid imaging or other imaging techniques in breast cancer

  • Hybrid imaging or other imaging techniques in lymphoma

  • Hybrid imaging or other imaging techniques in gastrointestinal cancers

  • Hybrid imaging or other imaging techniques in prostate cancer

  • Hybrid imaging or other imaging techniques in CNS/brain cancer

  • Hybrid imaging or other imaging techniques in lung cancer

  • Hybrid imaging or other imaging techniques in head and neck cancer and other malignancies

  • Hybrid imaging or other imaging techniques in benign conditions

  • Image guided therapy and radionuclide therapy

  • PET-CT in radiation treatment planning

  • Radiopharmaceutical production including good manufacturing practices and quality assurance

  • Imaging techniques physics, instrumentation and data analysis

  • Quality management in nuclear medicine and diagnostic imaging

  • Radiation protection for personnel and patients

  • Member State experience with PET, multimodality imaging and newer applications in diagnostic imaging, and related IAEA Projects

  • Ethics, leadership and education for nuclear medicine and diagnostic imaging professionals

  • General nuclear medicine, SPECT, and other

  • Radioguided surgery